Digital Ally (NASDAQ: DGLY), which develops, manufactures and markets advanced video surveillance products for law enforcement, homeland security and commercial applications, announced a partnership with Crime Stoppers International (CSI), the global authority on anonymous reporting. The sponsorship agreement will help to increase CSI’s awareness globally while increasing the visibility and availability of Digital Ally’s suite of advanced video surveillance products.

Why it Matters: Under the terms of the agreement, CSI will provide links to Digital Ally products on its main website as well as through member sites (such as Crime Stoppers USA and Canadian Crime Stoppers Association) that choose to participate. The association with a well-known organization like CSI should further enhance DGLY’s stature in the market while opening new sales opportunities.

Sorrento Therapeutics (NASDAQ: SRNE), a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases, issued a shareholder letter detailing multiple major milestone achievements and goals for the second half of 2018.

Why it Matters: Recent accomplishments, including a successful financing and the addition of the company’s stock to the Russell 3000 and 2000 indices, position SRNE for further success in 2018. The company expects to launch commercial sales of its recently approved ZTlido (lidocaine topical treatment) in the fourth quarter this year while its main development projects are progressing as planned. Clinical trials are being set-up for patient inclusion in CD38 CAR-T in refractory or relapsing multiple myeloma and RTX for osteoarthritis knee pain. And SRNE continues to expand its program pipeline with new IND enabling data generation (pre-clinical) in particular, in the areas of monoclonal antibody (PD-L1, in phase 1 trials in S. Korea and China) and CAR (BCMA) technologies.

Key Quote: “We strive to continue to execute on our business plan and move our development programs forward in the second half of 2018. We are encouraged by the high level of interest from outside parties and are evaluating strategic partnerships for some of our assets in development.” – Dr. Henry Ji, Chairman and CEO

Spectrum Global Solutions (OTC: SGSI), a single-source provider of end-to-end next-generation wireless and wireline network services and staffing solutions to the service provider (carrier) and corporate enterprise markets, has received over $1.2 million in new contract awards for network audit and deployment services to support next generation wireless and wireline services across the nation. 

Why it Matters: Work on the latest contract awards is already underway and SGSI anticipates realizing this revenue between Q2 and Q4 this year. Combined with its opportunity pipeline which is now reported as being greater than $135 million, SGSI is well-positioned for strong growth in 2018 and beyond.

Key Quote: “Spectrum’s full suite of services is allowing us to capitalize on this increased capital spending by carriers and enterprise clients. We continue to track at a $30 million plus annual revenue run rate.  We would expect this increase in revenue and earnings to translate into value for our shareholders near and long term.” – Roger Ponder, CEO

Disclosure

(Spectrum Global Solutions [OTC: SGSI] is a client of RedChip Companies, Inc. SGSI agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.)